Report Detail
Global Cyclophosphamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4668671 |
- 22 January, 2026 |
- Global |
- 100 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Cyclophosphamide market size was valued at US$ 703 million in 2025 and is forecast to a readjusted size of US$ 809 million by 2032 with a CAGR of 2.1% during review period.
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Top 8 manufacturers took 75.4% market share in 2019.
This report is a detailed and comprehensive analysis for global Cyclophosphamide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cyclophosphamide market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cyclophosphamide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cyclophosphamide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cyclophosphamide market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cyclophosphamide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cyclophosphamide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Novartis, Hikma Pharmaceuticals, Amneal Pharmaceuticals LLC, Jiangsu Hengrui Medicine, NorthStar Rx LLC, GLS Pharma, CSC Pharmaceuticals International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cyclophosphamide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
High-Dose
Low-Dose
Market segment by Application
Cancer
Autoimmune Diseases
AL Amyloidosis
Others
Major players covered
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC Pharmaceuticals International
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyclophosphamide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cyclophosphamide, with price, sales quantity, revenue, and global market share of Cyclophosphamide from 2021 to 2026.
Chapter 3, the Cyclophosphamide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclophosphamide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cyclophosphamide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclophosphamide.
Chapter 14 and 15, to describe Cyclophosphamide sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cyclophosphamide Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 High-Dose
- 1.3.3 Low-Dose
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cyclophosphamide Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Cancer
- 1.4.3 Autoimmune Diseases
- 1.4.4 AL Amyloidosis
- 1.4.5 Others
- 1.5 Global Cyclophosphamide Market Size & Forecast
- 1.5.1 Global Cyclophosphamide Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Cyclophosphamide Sales Quantity (2021-2032)
- 1.5.3 Global Cyclophosphamide Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Baxter
- 2.1.1 Baxter Details
- 2.1.2 Baxter Major Business
- 2.1.3 Baxter Cyclophosphamide Product and Services
- 2.1.4 Baxter Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Baxter Recent Developments/Updates
- 2.2 Novartis
- 2.2.1 Novartis Details
- 2.2.2 Novartis Major Business
- 2.2.3 Novartis Cyclophosphamide Product and Services
- 2.2.4 Novartis Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Novartis Recent Developments/Updates
- 2.3 Hikma Pharmaceuticals
- 2.3.1 Hikma Pharmaceuticals Details
- 2.3.2 Hikma Pharmaceuticals Major Business
- 2.3.3 Hikma Pharmaceuticals Cyclophosphamide Product and Services
- 2.3.4 Hikma Pharmaceuticals Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Hikma Pharmaceuticals Recent Developments/Updates
- 2.4 Amneal Pharmaceuticals LLC
- 2.4.1 Amneal Pharmaceuticals LLC Details
- 2.4.2 Amneal Pharmaceuticals LLC Major Business
- 2.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Product and Services
- 2.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
- 2.5 Jiangsu Hengrui Medicine
- 2.5.1 Jiangsu Hengrui Medicine Details
- 2.5.2 Jiangsu Hengrui Medicine Major Business
- 2.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Product and Services
- 2.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Jiangsu Hengrui Medicine Recent Developments/Updates
- 2.6 NorthStar Rx LLC
- 2.6.1 NorthStar Rx LLC Details
- 2.6.2 NorthStar Rx LLC Major Business
- 2.6.3 NorthStar Rx LLC Cyclophosphamide Product and Services
- 2.6.4 NorthStar Rx LLC Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 NorthStar Rx LLC Recent Developments/Updates
- 2.7 GLS Pharma
- 2.7.1 GLS Pharma Details
- 2.7.2 GLS Pharma Major Business
- 2.7.3 GLS Pharma Cyclophosphamide Product and Services
- 2.7.4 GLS Pharma Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 GLS Pharma Recent Developments/Updates
- 2.8 CSC Pharmaceuticals International
- 2.8.1 CSC Pharmaceuticals International Details
- 2.8.2 CSC Pharmaceuticals International Major Business
- 2.8.3 CSC Pharmaceuticals International Cyclophosphamide Product and Services
- 2.8.4 CSC Pharmaceuticals International Cyclophosphamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 CSC Pharmaceuticals International Recent Developments/Updates
3 Competitive Environment: Cyclophosphamide by Manufacturer
- 3.1 Global Cyclophosphamide Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Cyclophosphamide Revenue by Manufacturer (2021-2026)
- 3.3 Global Cyclophosphamide Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Cyclophosphamide by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Cyclophosphamide Manufacturer Market Share in 2025
- 3.4.3 Top 6 Cyclophosphamide Manufacturer Market Share in 2025
- 3.5 Cyclophosphamide Market: Overall Company Footprint Analysis
- 3.5.1 Cyclophosphamide Market: Region Footprint
- 3.5.2 Cyclophosphamide Market: Company Product Type Footprint
- 3.5.3 Cyclophosphamide Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Cyclophosphamide Market Size by Region
- 4.1.1 Global Cyclophosphamide Sales Quantity by Region (2021-2032)
- 4.1.2 Global Cyclophosphamide Consumption Value by Region (2021-2032)
- 4.1.3 Global Cyclophosphamide Average Price by Region (2021-2032)
- 4.2 North America Cyclophosphamide Consumption Value (2021-2032)
- 4.3 Europe Cyclophosphamide Consumption Value (2021-2032)
- 4.4 Asia-Pacific Cyclophosphamide Consumption Value (2021-2032)
- 4.5 South America Cyclophosphamide Consumption Value (2021-2032)
- 4.6 Middle East & Africa Cyclophosphamide Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Cyclophosphamide Sales Quantity by Type (2021-2032)
- 5.2 Global Cyclophosphamide Consumption Value by Type (2021-2032)
- 5.3 Global Cyclophosphamide Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Cyclophosphamide Sales Quantity by Application (2021-2032)
- 6.2 Global Cyclophosphamide Consumption Value by Application (2021-2032)
- 6.3 Global Cyclophosphamide Average Price by Application (2021-2032)
7 North America
- 7.1 North America Cyclophosphamide Sales Quantity by Type (2021-2032)
- 7.2 North America Cyclophosphamide Sales Quantity by Application (2021-2032)
- 7.3 North America Cyclophosphamide Market Size by Country
- 7.3.1 North America Cyclophosphamide Sales Quantity by Country (2021-2032)
- 7.3.2 North America Cyclophosphamide Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Cyclophosphamide Sales Quantity by Type (2021-2032)
- 8.2 Europe Cyclophosphamide Sales Quantity by Application (2021-2032)
- 8.3 Europe Cyclophosphamide Market Size by Country
- 8.3.1 Europe Cyclophosphamide Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Cyclophosphamide Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cyclophosphamide Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Cyclophosphamide Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Cyclophosphamide Market Size by Region
- 9.3.1 Asia-Pacific Cyclophosphamide Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Cyclophosphamide Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Cyclophosphamide Sales Quantity by Type (2021-2032)
- 10.2 South America Cyclophosphamide Sales Quantity by Application (2021-2032)
- 10.3 South America Cyclophosphamide Market Size by Country
- 10.3.1 South America Cyclophosphamide Sales Quantity by Country (2021-2032)
- 10.3.2 South America Cyclophosphamide Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cyclophosphamide Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Cyclophosphamide Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Cyclophosphamide Market Size by Country
- 11.3.1 Middle East & Africa Cyclophosphamide Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Cyclophosphamide Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Cyclophosphamide Market Drivers
- 12.2 Cyclophosphamide Market Restraints
- 12.3 Cyclophosphamide Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Cyclophosphamide and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cyclophosphamide
- 13.3 Cyclophosphamide Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cyclophosphamide Typical Distributors
- 14.3 Cyclophosphamide Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cyclophosphamide. Industry analysis & Market Report on Cyclophosphamide is a syndicated market report, published as Global Cyclophosphamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cyclophosphamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
